Mapping of the Epstein-Barr virus and C3dg binding sites to a common domain on complement receptor type 2.

The Journal of Experimental Medicine
C A LowellJ M Ahearn

Abstract

Complement receptor type 2 (CR2;CD21), a member of the superfamily of proteins containing short consensus repeats (SCRs), is the B cell receptor for both the gp350/220 envelope protein of Epstein-Barr virus (EBV), and for the C3dg protein of complement. By analysis of CR2 deletion mutants and chimeras formed with CR1 (CD35) we determined that of the 15 SCRs in CR2, the NH2-terminal two SCRs are necessary and sufficient to bind both gp350/220 and C3dg with affinities equivalent to those of the wild-type receptor. The epitope for OKB-7, a mAb that blocks binding of both EBV and C3dg and shares with these ligands B cell-activating capabilities, also requires both SCR-1 and SCR-2, whereas mAbs lacking these functions bind to other SCRs. Thus, EBV, a polyclonal activator of B cells, has selected a site that is proximate or identical to the natural ligand binding site in CR2, perhaps reflecting the relative immutability of that site as well as its signal transducing function.

References

Dec 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·F SangerA R Coulson
May 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·J M RojoC A Janeway
Feb 23, 1989·The New England Journal of Medicine·L M WeissJ Sklar
Mar 10, 1989·Cell·J M White, D R Littman
Apr 7, 1989·Cell·B Sugden
Dec 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·M D MooreG R Nemerow
Dec 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·J M AhearnD T Fearon
Aug 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·R J RobbM P Neeper
Jan 1, 1986·The Journal of Experimental Medicine·P S Changelian, D T Fearon
Jul 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·J D FingerothD T Fearon
Jun 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·B DahlbäckH J Müller-Eberhard
Feb 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·J J WeisD T Fearon
May 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·G J HoffmanS D Hayward
Jun 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·J LozierF W Putnam

❮ Previous
Next ❯

Citations

Aug 26, 1998·Clinical Immunology and Immunopathology·M Tolnay, G C Tsokos
Jan 1, 1994·Springer Seminars in Immunopathology·K R KalliD T Fearon
Jan 1, 1991·Immunologic Research·S R Barnum
May 8, 2003·Journal of Biosciences·John BernetArvind Sahu
Feb 1, 1993·Immunology Today·C D Tsoukas, J D Lambris
Jul 17, 1999·Immunopharmacology·V Frémeaux-BacchiE M Fischer
Jul 1, 1997·Virus Research·M Kearns-JonkerG Sigounas
Apr 26, 2003·Cell Biology International·Maria Grazia Di CertoGiuseppe Barile
May 1, 1996·Quarterly Reviews of Biophysics·P BorkI D Campbell
Sep 16, 1998·Clinical and Experimental Immunology·N R LingI C MacLennan
May 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·M KrychJ P Atkinson
Apr 1, 1991·The Journal of Experimental Medicine·D WatryC D Tsoukas
Dec 1, 1991·The Journal of Experimental Medicine·K R KalliD T Fearon
Nov 1, 1992·The Journal of Experimental Medicine·M BirkenbachE Kieff
Oct 1, 1993·The Journal of Experimental Medicine·A K MatsumotoD T Fearon
Jan 7, 1998·Immunological Reviews·C SpethM P Dierich
Aug 13, 1998·Immunological Reviews·I D Campbell
Jul 18, 2002·Proceedings of the National Academy of Sciences of the United States of America·Andrea E ProtaJoyce D Fingeroth
Oct 31, 2006·Nature Structural & Molecular Biology·Gerda SzakonyiXiaojiang S Chen
Apr 30, 2011·Science·Jean M H van den Elsen, David E Isenman
Oct 31, 2001·Journal of Immunological Methods·S E HensonD R Karp
Sep 1, 1992·Leukemia & Lymphoma·F Lanza, G Castoldi
Feb 5, 2013·The Journal of Allergy and Clinical Immunology·Nima ParvanehMary Ellen Conley
Aug 1, 1992·Immunobiology·N R Ling, B Brown
Dec 6, 2011·Journal of Neuroimmunology·Nicole ToepfnerBernhard Hemmer
Nov 1, 2011·The Journal of Allergy and Clinical Immunology·Jens ThielMichael Schlesier
Oct 19, 2010·Journal of Molecular Biology·Craig D ShawJonathan P Hannan
Apr 17, 2007·Journal of Molecular Biology·Li ZhangDimitrios Morikis
Aug 20, 2008·Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology·Ru JiangLindsey Hutt-Fletcher
Aug 1, 2006·Molecular Immunology·Bert J C Janssen, Piet Gros
Sep 1, 1991·The Journal of Allergy and Clinical Immunology·D Vercelli, R S Geha

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.